Back
Mineralys Therapeutics Stock Price Chart
Hidden Stock Under $5 Holds Tech World Hostage
Click here to see more.
Sell
38
MLYS
Mineralys Therapeutics
Last Price:
$12.74
Seasonality Move:
51.51%
7 Day Trial
ALL ACCESS PASS
$
7
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLYS is experiencing slight buying pressure.
Mineralys Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.55 | Buy |
| 20-day SMA: | 12.48 | Buy |
| 50-day SMA: | 12.9 | Sell |
| 200-day SMA: | 12.6 | Buy |
| 8-day EMA: | 12.5 | Buy |
| 20-day EMA: | 12.52 | Buy |
| 50-day EMA: | 12.68 | Buy |
| 200-day EMA: | 12.59 | Buy |
Mineralys Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.08 | Sell |
| Relative Strength Index (14 RSI): | 51.91 | Buy |
| Chaikin Money Flow: | 66710 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (12.1 - 13.06) | Buy |
| Bollinger Bands (100): | (11.49 - 13.61) | Buy |
Mineralys Therapeutics Technical Analysis
| Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | Jan | |||||||||
| 19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Mineralys Therapeutics Stock
Is Mineralys Therapeutics Stock a Buy?
-
Mineralys Therapeutics share price is 12.75 while MLYS 8-day simple moving average is 12.55, which is a Buy signal.
-
The stock price of MLYS is 12.75 while Mineralys Therapeutics 20-day SMA is 12.48, which makes it a Buy.
-
Mineralys Therapeutics 50-day simple moving average is 12.90 while MLYS share price is 12.75, making it a Sell technically.
-
MLYS stock price is 12.75 and Mineralys Therapeutics 200-day simple moving average is 12.60, creating a Buy signal.
MLYS Technical Analysis vs Fundamental Analysis
Sell
38
Mineralys Therapeutics (MLYS)
is a Sell
Is Mineralys Therapeutics a Buy or a Sell?
-
Mineralys Therapeutics stock is rated a SellThe current Mineralys Therapeutics [MLYS] share price is $12.75. The Score for MLYS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
Mineralys Therapeutics Stock Info
Market Cap:
634.6M
Price in USD:
12.75
Share Volume:
158.2K
Mineralys Therapeutics 52-Week Range
52-Week High:
16.91
52-Week Low:
7.95
Sell
38
Mineralys Therapeutics (MLYS)
is a Sell
Mineralys Therapeutics Share Price Forecast
-
What is the Mineralys Therapeutics stock price today?The Mineralys Therapeutics stock price is 12.75 USD today.
-
Will MLYS stock go up or go down?Mineralys Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Mineralys Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Mineralys Therapeutics is overvalued.
Is Mineralys Therapeutics Stock a Buy?
-
Mineralys Therapeutics share price is 12.75 while MLYS 8-day exponential moving average is 12.50, which is a Buy signal.
-
The stock price of MLYS is 12.75 while Mineralys Therapeutics 20-day EMA is 12.52, which makes it a Buy.
-
Mineralys Therapeutics 50-day exponential moving average is 12.68 while MLYS share price is 12.75, making it a Buy technically.
-
MLYS stock price is 12.75 and Mineralys Therapeutics 200-day simple moving average is 12.59, creating a Buy signal.
Fundamental Analysis of Mineralys Therapeutics
Is Mineralys Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and an increase next year of $0.34 per share.
Technical Analysis of Mineralys Therapeutics
Should I short Mineralys Therapeutics stock?
-
MLYS Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Mineralys Therapeutics is a Sell
-
Mineralys Therapeutics Relative Strength Index (RSI) is 51.91, which suggest Mineralys Therapeutics is overbought
-
The Bollinger Bands (25) for Mineralys Therapeutics is (12.1 - 13.06), which suggest Mineralys Therapeutics is a Buy
-
The Bollinger Bands (100) for Mineralys Therapeutics is (11.49 - 13.61), which suggest Mineralys Therapeutics is a Buy
* Mineralys Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.